Table 1 Patient characteristics on admission
Patient characteristics | Study population |
|---|---|
N = 1320 | |
Age, median (IQR) | 71 (58–81) |
Gender, male | 47% (626) |
Nursing home, Yes | 11% (145) |
Co-morbidities | |
COPD | 19% (243) |
Asthma | 8% (105) |
Other chronic respiratory diseasea | 4% (49) |
Malignancy | 9% (119) |
Chronic heart disease | 24% (320) |
Chronic liver disease | 1% (12) |
Chronic kidney failure | 3% (41) |
Chronic neurological disease | 14% (188) |
Diabetes | 12% (162) |
Number of comorbidities | |
One | 35% (466) |
More than one | 25% (325) |
Biochemistry, median (IQR) | |
CRP, mg/l | 108 (47–214) |
White blood cell count, x 109/l | 12.2 (9.2–15.7) |
Urea, mmol/l | 6 (4–9) |
Vital parameters on admission, median (IQR) | |
Diastolic blood pressure, mmHg | 75 (65–85) |
Systolic blood pressure, mmHg | 133 (119–149) |
Pulse rate,/min | 94 (81–106) |
Respiratory rate,/min | 20 (16–24) |
Temperature, °C | 37.7 (37.0–38.5) |
Oxygen therapy | 58% (744) |
Findings on chest x-ray | |
Multilobar infiltrate | 31% (403) |
Risk assessment | |
CURB-65: 0–1 | 53% (605) |
CURB-65: 2 | 29% (330) |
CURB-65: 3–5 | 18% (202) |
Antibiotic treatmentb | |
Penicillin-G/V monotherapyc | 45% (590) |
Penicillin-G/V in combinationd | 6% (74) |
Macrolide monotherapy | 3% (36) |
Other beta-lactam monotherapye | 30% (396) |
Other beta-lactam in combinationd | 10% (132) |
Other | 7% (92) |